摘要
目的探讨晚期非小细胞肺癌(NSCLC)患者经胸腔镜辅助氩氦刀治疗前后血清CEA、CYFRA21-1、CA125水平的变化。方法测定30例晚期NSCLC患者胸腔镜辅助氩氦刀治疗前后血清CEA、CYFRA21-1、CA125的水平。结果胸腔镜辅助氩氦刀治疗后NSCLC患者血清CEA、CYFRA21-1、CA125水平较治疗前显著下降(P均<0.05)。结论晚期NSCLC患者经胸腔镜辅助氩氦刀治疗后可以下调CEA、CYFRA21-1、CA125水平,通过监测其水平改变有助于手术疗效的评估。
Objective To investigate serum levels of CEA,CYFRA21-1 and CA125 in the advanced non-small cell lung cancer（NSCLC）before and after thoracoscope assisted argon-helium knife. Methods The serum levels of CEA,CYFRA21-1 and CA125 were measured in the 30 patients with advanced NSCLC before and after thoraco-scope assisted argon-helium knife. Results The serum levels of CEA,CYFRA21-1,CA125 in the patients with advanced NSCLC after thoracoscope assisted argon-helium knife were lower than those before thoracoscope assisted argon-helium knife（P ＆lt; 0. 05）. Conclusion Thoracoscope assisted argon-helium knife can decrease the serum levels of CEA,CYFRA21-1 and CA125 in the patients with advanced NSCLC,monitor of their levels could be help-ful to evaluate the effects of surgery.
出处
《肿瘤基础与临床》
2014年第2期147-148,共2页
journal of basic and clinical oncology
关键词
胸腔镜
氩氦刀
非小细胞肺癌
肿瘤标志物
thoracoscope
argon-helium knife
non-small cell lung cancer
tumor marker
